<noscript id="2mmmm"><acronym id="2mmmm"></acronym></noscript>
  • <tt id="2mmmm"></tt>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
  • <table id="2mmmm"></table>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
    <tt id="2mmmm"><table id="2mmmm"></table></tt>
    中文
    中文
    為了病患而驅動(dòng)的創(chuàng )新
    Patient-first cell therapy innovation

    2021
    • 0
    Cancer Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppression.
    Nat Cell Biol. Author manuscript; available in PMC: 2022 Aug 10.
    Published in final edited form as: Nat Cell Biol. 2022 Feb 10;24(2):230–241. doi: 10.1038/s41556-021-00820-9
    Huang D., Wang Y., Thompson J.W., Yin T., Alexander P.B., Qin D., Mudgal P., Wu H., Liang Y., Tan L., Pan C., Yuan L., Wan Y., Li Q.-J.,* and Wang X.F. (2021)

    The lupus autoantigen La/Ssb is an Xist-binding protein involved in Xist folding and cloud formation.
    Nucleic Acids Res. (20):11596-11613. (*: Corresponding authors, PMCID: PMC8599922)
    Ha N., Ding N., Hong R., Liu R., Roca X., Luo Y., Duan X., Wang X., Ni P., Wu H., Zhang L.F.*, Chen L*. (2021) 

    TIPS: trajectory inference of pathway significance through pseudotime comparison for functional assessment of single-cell RNAseq data.
    Brief Bioinform. 22(5):bbab124. (*: Corresponding authors, PMCID: PMC8425418)
    Zheng Z., Qiu X., Wu H., Chang L., Tang X., Zou L., Li J., Wu Y., Zhou J., Jiang S., Wan Y., Ni Q. (2021) 

     TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma.
    Oncoimmunology. 10(1):1955545. (*: Corresponding authors, PMCID: PMC8331028)
    Wang G., Mudgal P., Wang L., Shuen T.W.H., Wu H., Alexander P.B., Wang W.W., Wan Y., Toh H.C.*, Wang X.-F.*, and Li Q.-J.* (2021)

    Resident Memory T Cells in Tumor-Distant Tissues Fortify Against Metastasis Formation.
    Cell Reports 35(6)109118 (PMCID: PMC8204287)
    Christian L.S., Wang L., Wu H., Deng D., Lim B., Wang X.-F. and Li Q.-J. (2021)

    Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma.
    Theranostics 11(10):4699-4709. (*: Corresponding authors, PMCID: PMC7978305)
    Jia Q., Qin D., He F., Xie Q., Ying Z., Zhang Y., Song Y., Cheng J.N., Zuo X., Xu L., Fang H., Hu C., Peng L., Jin T., Shi Z., Alexander P.B., Wang Y., Liu Y., Han W., Zhu J., Wang P.*, Li Q.-J.*, Zhu B.* (2021) 

    Radiation-Induced Eosinophils Improve Cytotoxic T Lymphocyte Recruitment and Response to Immunotherapy.
    Sci. Adv. 7(5):eabc7609. (*: Corresponding authors, PMCID: PMC7846170)
    Cheng J.-N., Luo W., Sun C., Jin Z., Zeng X., Alexander P.B., Gong Z., Xia X., Ding X., Xu S., Zou P., Wan Y., Jia Q. *, Li Q.-J.*, & Zhu B. (2021)

    The Landscape of Cell and Gene Therapies for Solid Tumors.
    Cancer Cell. 39(1):7-8. (PMID: 33434513)
    Wang S., Sun F., Huang H., Chen K., Li Q.J., Zhang L., Wang E., Wang C., Zhang H., Yuan A.Q., Chen B., Deng T., Liu Y., Sun J., Liu D., Yu Y., Fang Y., Jiang N., Wu D., Fang H., Bai Y., Xing S., Ni Y., Fan Q., Yu A., Sun C., Tang Y., Li N., Xu B., He J. (2021) 
    03.23
    2022
    來(lái)源:
    關(guān)鍵詞:
    相關(guān)閱讀

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    關(guān)于天科雅
    研究與發(fā)展
    產(chǎn)品及臨床
    新聞與媒體
    招賢納士

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    精品无码国产自产在线观看水浒传_西西人体444WwW高清大胆_国产探花在线精品一区二区_成人试看120秒体验区